---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-09T10:05:08.675665'
end_time: '2026-02-09T10:09:00.455385'
duration_seconds: 231.78
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: CRYAA
  gene_symbol: CRYAA
  uniprot_accession: P02489
  protein_description: 'RecName: Full=Alpha-crystallin A chain; AltName: Full=Heat
    shock protein beta-4; Short=HspB4; AltName: Full=Heat shock protein family B member
    4; Contains: RecName: Full=Alpha-crystallin A(1-172); Contains: RecName: Full=Alpha-crystallin
    A(1-168); Contains: RecName: Full=Alpha-crystallin A(1-162);'
  gene_info: Name=CRYAA; Synonyms=CRYA1, HSPB4;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the small heat shock protein (HSP20) family.
  protein_domains: A-crystallin/Hsp20_dom. (IPR002068); Alpha-crystallin/HSP_16. (IPR055269);
    Alpha-crystallin/sHSP_animal. (IPR001436); Alpha-crystallin_N. (IPR003090); HSP20-like_chaperone.
    (IPR008978)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 15
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P02489
- **Protein Description:** RecName: Full=Alpha-crystallin A chain; AltName: Full=Heat shock protein beta-4; Short=HspB4; AltName: Full=Heat shock protein family B member 4; Contains: RecName: Full=Alpha-crystallin A(1-172); Contains: RecName: Full=Alpha-crystallin A(1-168); Contains: RecName: Full=Alpha-crystallin A(1-162);
- **Gene Information:** Name=CRYAA; Synonyms=CRYA1, HSPB4;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the small heat shock protein (HSP20) family.
- **Key Domains:** A-crystallin/Hsp20_dom. (IPR002068); Alpha-crystallin/HSP_16. (IPR055269); Alpha-crystallin/sHSP_animal. (IPR001436); Alpha-crystallin_N. (IPR003090); HSP20-like_chaperone. (IPR008978)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "CRYAA" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'CRYAA' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **CRYAA** (gene ID: CRYAA, UniProt: P02489) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P02489
- **Protein Description:** RecName: Full=Alpha-crystallin A chain; AltName: Full=Heat shock protein beta-4; Short=HspB4; AltName: Full=Heat shock protein family B member 4; Contains: RecName: Full=Alpha-crystallin A(1-172); Contains: RecName: Full=Alpha-crystallin A(1-168); Contains: RecName: Full=Alpha-crystallin A(1-162);
- **Gene Information:** Name=CRYAA; Synonyms=CRYA1, HSPB4;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the small heat shock protein (HSP20) family.
- **Key Domains:** A-crystallin/Hsp20_dom. (IPR002068); Alpha-crystallin/HSP_16. (IPR055269); Alpha-crystallin/sHSP_animal. (IPR001436); Alpha-crystallin_N. (IPR003090); HSP20-like_chaperone. (IPR008978)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "CRYAA" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'CRYAA' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **CRYAA** (gene ID: CRYAA, UniProt: P02489) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive research report: CRYAA (alphaA-crystallin/HSPB4; UniProt P02489) in human

1. Identity, key concepts, and definitions
- Gene/protein identity and family: CRYAA encodes alphaA-crystallin (HSPB4), a small heat shock protein (sHSP) subunit of the alpha-crystallins. sHSPs share a conserved α‑crystallin domain flanked by variable N- and C-termini and assemble into oligomers with holdase chaperone activity. HSPB4 can hetero-oligomerize with HSPB5 (αB‑crystallin). These features, including domain organization and sHSP family membership, are documented in recent reviews and primary studies focused on HSPB4 regulation and function (URL: https://doi.org/10.3390/cells13232000; Dec 2024) (sluzala2024novelmtorc2hspb4interaction pages 1-2, sluzala2024novelmtorc2hspb4interaction pages 14-15, sluzala2024novelmtorc2hspb4interaction pages 17-18).
- Core molecular function: As a chaperone, HSPB4 binds partially unfolded proteins to prevent misfolding and aggregation, thereby maintaining lens proteostasis and cell survival; mutational changes in the α‑crystallin/sHSP domain impair chaperone activity (URL: https://doi.org/10.3390/cells13232000; Dec 2024) (sluzala2024novelmtorc2hspb4interaction pages 14-15, sluzala2024novelmtorc2hspb4interaction pages 17-18). Population and mechanistic cataract studies reaffirm the central role of CRYAA in lens transparency (URL: https://doi.org/10.3390/cimb45060327; Jun 2023) (khidiyatova2023studyofthe pages 11-13) and the proteostasis function of CRYAA in stress (URL: https://doi.org/10.1172/jci169666; Sep 2024) (yang2024reversiblecoldinducedlens pages 3-6).

2. Structure, oligomerization, and post-translational regulation
- Oligomerization and structural features: Phosphorylation and sequence variants alter HSPB4 oligomer size, subunit exchange, and chaperone performance, consistent with sHSP regulation paradigms described for α‑crystallins (URL: https://doi.org/10.3390/cells13232000; Dec 2024) (sluzala2024novelmtorc2hspb4interaction pages 14-15, sluzala2024novelmtorc2hspb4interaction pages 17-18, sluzala2024novelmtorc2hspb4interaction pages 1-2).
- Key post-translational modifications: Threonine 148 (T148) phosphorylation in human HSPB4 is a critical regulatory site. Functional data show phosphomimetic T148D improves chaperone activity and solubility, while T148A abrogates these effects; T148 phosphorylation is detected in lens and retina and is reduced in diabetes/diabetic retinopathy (URL: https://doi.org/10.3390/cells13232000; Dec 2024) (sluzala2024novelmtorc2hspb4interaction pages 1-2). Kinome profiling and chemoproteomics identify mTORC2 as a strong candidate kinase for T148, and the study delineates a multifaceted HSPB4–mTORC2 interaction (URL: https://doi.org/10.3390/cells13232000; Dec 2024) (sluzala2024novelmtorc2hspb4interaction pages 1-2, sluzala2024novelmtorc2hspb4interaction pages 17-18).

3. Cellular and tissue localization
- Ocular expression: HSPB4 is abundant in lens fiber cells and is also expressed in retinal neurons and glia, consistent with roles in lens transparency and retinal neuroprotection (URL: https://doi.org/10.3390/cells13232000; Dec 2024) (sluzala2024novelmtorc2hspb4interaction pages 1-2, sluzala2024novelmtorc2hspb4interaction pages 17-18). Zebrafish work supports conserved, fiber cell–biased expression of cryaa during early lens development and highlights functional conservation with human CRYAA (URL: https://doi.org/10.3389/fcell.2025.1552988; Mar 2025) (rossen2025zebrafishasa pages 3-4).

4. Interacting pathways and proteostasis mechanisms
- mTORC2 signaling and HSPB4: Evidence supports direct interaction between HSPB4 and mTORC2, with mTORC2 implicated in HSPB4 T148 phosphorylation. This post-translational control links stress signaling to HSPB4 chaperone capacity and neuroprotective function in ocular tissues (URL: https://doi.org/10.3390/cells13232000; Dec 2024) (sluzala2024novelmtorc2hspb4interaction pages 1-2, sluzala2024novelmtorc2hspb4interaction pages 17-18).
- Ubiquitin–proteasome system (UPS) and RNF114: A 2024 mechanistic study in a hibernator model showed that aggregated/mutant CRYAA produced during cold stress–rewarming is turned over predominantly by the proteasome, not lysosomal autophagy. An E3 ligase, RNF114, binds CRYAA, promotes its polyubiquitination, and accelerates proteasomal degradation. In vivo delivery of a TAT‑RNF114 complex reduced lens opacity in rat cold‑cataract and zebrafish oxidative cataract models, nominating RNF114‑mediated CRYAA turnover as a therapeutic modality (URL: https://doi.org/10.1172/jci169666; Sep 2024) (yang2024reversiblecoldinducedlens pages 3-6).

5. Disease associations, recent variants, and mechanistic impact
- Congenital and age-related cataract: CRYAA mutations commonly cause dominant congenital cataracts (often nuclear/zonular), with numerous pathogenic missense alleles concentrated in the N‑terminal and α‑crystallin domains (e.g., p.R12C, p.R21W/L, p.R49C, p.R54C, p.G98R, p.R116C/H). Stop‑loss/C‑terminal extension alleles and rare recessive variants are reported. These mutations generally impair chaperone function and promote aggregation (URL: https://doi.org/10.3390/cimb45060327; Jun 2023) (khidiyatova2023studyofthe pages 11-13). A 2024 perspective on cataract genetics further contextualizes CRYAA among major cataract genes (URL: https://doi.org/10.3390/genes15060785; Jun 2024) (sluzala2024novelmtorc2hspb4interaction pages 17-18).
- Recent cohort data and novel CRYAA variants (2023–2024): In a Volga–Ural cohort (45 unrelated families), likely pathogenic variants were found in 10 families; two novel CRYAA missense variants, p.L85F and p.H97Q, were identified (autosomal dominant congenital cataracts). The study also summarizes ~26 known pathogenic CRYAA variants overall (URL: https://doi.org/10.3390/cimb45060327; Jun 2023) (khidiyatova2023studyofthe pages 11-13).
- Lens epithelial biology: A 2024 study showed CRYAA E156K drives epithelial–mesenchymal transition (EMT) and increases migration in human lens epithelial cells, with increased nuclear β‑catenin and elevated p‑FAK/p‑Src; β‑catenin/FAK/Src inhibitors reversed these phenotypes. These data mechanistically connect mutant CRYAA to pathways relevant for posterior subcapsular cataract and posterior capsule opacification (URL: https://doi.org/10.1016/j.heliyon.2023.e23690; Jan 2024) (zhao2024thee156kmutation pages 4-7, zhao2024thee156kmutation pages 7-9).

6. Current applications and real-world implementations
- Therapeutic modulation of CRYAA proteostasis: The 2024 JCI study provides in vivo proof-of-concept for delivering an E3 ligase (TAT‑RNF114) to enhance mutant/aggregated CRYAA clearance and reduce lens opacity in animal models, suggesting a translational route to medical anti‑cataract therapy beyond surgery (URL: https://doi.org/10.1172/jci169666; Sep 2024) (yang2024reversiblecoldinducedlens pages 3-6).
- Targeting post-translational regulation: Given that T148 phosphorylation enhances CRYAA chaperone function and is decreased in diabetic retinopathy, strategies to restore T148 phosphorylation (e.g., via mTORC2 modulation) are proposed as neuroprotective approaches in retinal disease and potentially cataract contexts, though this remains preclinical (URL: https://doi.org/10.3390/cells13232000; Dec 2024) (sluzala2024novelmtorc2hspb4interaction pages 1-2, sluzala2024novelmtorc2hspb4interaction pages 17-18).

7. Expert opinions and recent reviews
- Oxidative stress and cataracts: A 2024 review emphasizes oxidative stress as a central factor in cataractogenesis and integrates genetic contributors, noting CRYAA among crystallin genes implicated in both congenital and potentially age-related cataracts (URL: https://doi.org/10.3390/antiox13111315; Oct 2024) (zhao2024thee156kmutation pages 7-9). A 2024 genetics perspective highlights CRYAA within the Cat‑Map framework of cataract genes and discusses gene‑based therapeutic prospects (URL: https://doi.org/10.3390/genes15060785; Jun 2024) (sluzala2024novelmtorc2hspb4interaction pages 17-18).

8. Relevant statistics and data (recent)
- Familial congenital cataract cohort (Volga–Ural): Pathogenic/probable pathogenic variants detected in 10/45 unrelated families (22.2%); two novel CRYAA variants (p.L85F, p.H97Q) were among the causative alleles identified across crystallin and connexin genes (URL: https://doi.org/10.3390/cimb45060327; Jun 2023) (khidiyatova2023studyofthe pages 11-13).
- Burden and clinical relevance: Cataracts remain a leading cause of blindness worldwide; genetic and redox pathway analyses outline glutathione-centered detoxification as key to lens homeostasis, contextualizing why chaperone deficits from CRYAA mutations increase cataract risk (URL: https://doi.org/10.3390/antiox13111315; Oct 2024) (zhao2024thee156kmutation pages 7-9).
- Mechanistic in vivo efficacy: TAT‑RNF114 reduced cold‑induced lens opacity in rats and oxidative cataract in zebrafish, supporting therapeutic feasibility of targeting CRYAA proteostasis via the UPS (URL: https://doi.org/10.1172/jci169666; Sep 2024) (yang2024reversiblecoldinducedlens pages 3-6).

9. Verification of identity and avoidance of symbol ambiguity
- The literature consistently refers to alphaA‑crystallin as HSPB4 (also called αA‑crystallin), encoded by CRYAA in human ocular tissues, with α‑crystallin domain architecture characteristic of the sHSP family—matching the UniProt P02489 description and domains (URL: https://doi.org/10.3390/cells13232000; Dec 2024) (sluzala2024novelmtorc2hspb4interaction pages 1-2, sluzala2024novelmtorc2hspb4interaction pages 14-15, sluzala2024novelmtorc2hspb4interaction pages 17-18). No conflicting gene symbol usage was encountered in the cited 2023–2024 sources.

Conclusions and outlook
CRYAA (HSPB4) is a canonical sHSP chaperone critical for lens proteostasis, with functions governed by oligomeric state and post‑translational regulation. Recent advances highlight: (i) phosphorylation at T148—likely mediated by mTORC2—as a key enhancer of chaperone activity; and (ii) the ubiquitin–proteasome pathway, via RNF114, as a determinant of CRYAA turnover with translational potential for anti‑cataract therapy. New human variants (e.g., p.L85F, p.H97Q; 2023) and mechanistic cell studies (E156K‑driven EMT/migration; 2024) deepen links between CRYAA dysfunction and cataract pathology, including lens epithelial remodeling. Together, these findings refine molecular targets—post‑translational control and targeted proteostasis—for future interventions in inherited and possibly acquired cataracts (sluzala2024novelmtorc2hspb4interaction pages 1-2, yang2024reversiblecoldinducedlens pages 3-6, zhao2024thee156kmutation pages 4-7, zhao2024thee156kmutation pages 7-9, khidiyatova2023studyofthe pages 11-13, sluzala2024novelmtorc2hspb4interaction pages 17-18).

References

1. (sluzala2024novelmtorc2hspb4interaction pages 1-2): Zachary B. Sluzala, Yang Shan, Lynda Elghazi, Emilio L. Cárdenas, Angelina Hamati, Amanda L. Garner, and Patrice E. Fort. Novel mtorc2/hspb4 interaction: role and regulation of hspb4 t148 phosphorylation. Cells, 13:2000, Dec 2024. URL: https://doi.org/10.3390/cells13232000, doi:10.3390/cells13232000. This article has 3 citations and is from a poor quality or predatory journal.

2. (sluzala2024novelmtorc2hspb4interaction pages 14-15): Zachary B. Sluzala, Yang Shan, Lynda Elghazi, Emilio L. Cárdenas, Angelina Hamati, Amanda L. Garner, and Patrice E. Fort. Novel mtorc2/hspb4 interaction: role and regulation of hspb4 t148 phosphorylation. Cells, 13:2000, Dec 2024. URL: https://doi.org/10.3390/cells13232000, doi:10.3390/cells13232000. This article has 3 citations and is from a poor quality or predatory journal.

3. (sluzala2024novelmtorc2hspb4interaction pages 17-18): Zachary B. Sluzala, Yang Shan, Lynda Elghazi, Emilio L. Cárdenas, Angelina Hamati, Amanda L. Garner, and Patrice E. Fort. Novel mtorc2/hspb4 interaction: role and regulation of hspb4 t148 phosphorylation. Cells, 13:2000, Dec 2024. URL: https://doi.org/10.3390/cells13232000, doi:10.3390/cells13232000. This article has 3 citations and is from a poor quality or predatory journal.

4. (khidiyatova2023studyofthe pages 11-13): Irina Khidiyatova, Indira Khidiyatova, Rena Zinchenko, Andrey Marakhonov, Alexandra Karunas, Svetlana Avkhadeeva, Marat Aznzbaev, and Elza Khusnutdinova. Study of the molecular nature of congenital cataracts in patients from the volga–ural region. Current Issues in Molecular Biology, 45:5145-5163, Jun 2023. URL: https://doi.org/10.3390/cimb45060327, doi:10.3390/cimb45060327. This article has 1 citations and is from a poor quality or predatory journal.

5. (yang2024reversiblecoldinducedlens pages 3-6): Hao Yang, Xiyuan Ping, Jiayue Zhou, Hailaiti Ailifeire, Jing Wu, Francisco M. Nadal-Nicolás, Kiyoharu J. Miyagishima, Jing Bao, Yuxin Huang, Yilei Cui, Xin Xing, Shiqiang Wang, Ke Yao, Wei Li, and Xingchao Shentu. Reversible cold-induced lens opacity in a hibernator reveals a molecular target for treating cataracts. The Journal of Clinical Investigation, Sep 2024. URL: https://doi.org/10.1172/jci169666, doi:10.1172/jci169666. This article has 12 citations.

6. (rossen2025zebrafishasa pages 3-4): Jennifer L. Rossen, Antionette L. Williams, and Brenda L. Bohnsack. Zebrafish as a model for crystallin-associated congenital cataracts in humans. Frontiers in Cell and Developmental Biology, Mar 2025. URL: https://doi.org/10.3389/fcell.2025.1552988, doi:10.3389/fcell.2025.1552988. This article has 2 citations and is from a poor quality or predatory journal.

7. (zhao2024thee156kmutation pages 4-7): Zhennan Zhao, Jiahui Chen, Yongxiang Jiang, and Yi Lu. The e156k mutation in the cryaa gene affects the epithelial–mesenchymal transition and migration of human lens epithelial cells. Heliyon, 10:e23690, Jan 2024. URL: https://doi.org/10.1016/j.heliyon.2023.e23690, doi:10.1016/j.heliyon.2023.e23690. This article has 0 citations and is from a peer-reviewed journal.

8. (zhao2024thee156kmutation pages 7-9): Zhennan Zhao, Jiahui Chen, Yongxiang Jiang, and Yi Lu. The e156k mutation in the cryaa gene affects the epithelial–mesenchymal transition and migration of human lens epithelial cells. Heliyon, 10:e23690, Jan 2024. URL: https://doi.org/10.1016/j.heliyon.2023.e23690, doi:10.1016/j.heliyon.2023.e23690. This article has 0 citations and is from a peer-reviewed journal.

## Citations

1. khidiyatova2023studyofthe pages 11-13
2. yang2024reversiblecoldinducedlens pages 3-6
3. rossen2025zebrafishasa pages 3-4
4. https://doi.org/10.3390/cells13232000;
5. https://doi.org/10.3390/cimb45060327;
6. https://doi.org/10.1172/jci169666;
7. https://doi.org/10.3389/fcell.2025.1552988;
8. https://doi.org/10.3390/genes15060785;
9. https://doi.org/10.1016/j.heliyon.2023.e23690;
10. https://doi.org/10.3390/antiox13111315;
11. https://doi.org/10.3390/cells13232000,
12. https://doi.org/10.3390/cimb45060327,
13. https://doi.org/10.1172/jci169666,
14. https://doi.org/10.3389/fcell.2025.1552988,
15. https://doi.org/10.1016/j.heliyon.2023.e23690,